3 ms·
> The primary issue is that vaccines are becoming a very large percentage of pharmas profits [Citation needed]. Vaccines are practically sold at break-even cos
by Analemma_ 7y ago
> The primary issue is that vaccines are becoming a very large percentage of pharmas profits
[Citation needed]. Vaccines are practically sold at break-even cost, and in fact in the last few decades many companies have exited the vaccine market entirely because there was so little money to be made.
> as well as there being protections for the industry to prevent people for suing them if a vaccine turns out to be actually unsafe
These liability protections exist because vaccines are so unprofitable. If you didn't have indemnity for a product that both
a) gets distributed to almost everyone, and so even tiny probabilities of side effects result in large absolute numbers of cases
b) has a tiny profit margin
no one would ever take on that risk, and the only way for vaccines to get made would be from nationalized industries.
- sschueller 7y agohttps://www.statista.com/statistics/265102/revenues-in-the-global-vaccine-market/ https://www.statista.com/statistics/265102/revenues-in-the-g... https://www.cnbc.com/2019/05/10/merck-pfizer-sanofi-pasteur-and-glaxosmithkline-make-billions-from-shingrix-and-gardasil-vaccines.html https://www.cnbc.com/2019/05/10/merck-pfizer-sanofi-pasteur-...